Nomura Holdings
SRPT icon

Nomura Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Nomura Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,400
Closed -$826K – 2092
2025
Q4 		$826K Sell
38,400
-113,500
-75% -$2.39M ﹤0.01% 1393
2025
Q3 		$2.93M Buy
151,900
+53,700
+55% +$957K ﹤0.01% 991
2025
Q2 		$1.68M Buy
98,200
+7,100
+8% +$303K ﹤0.01% 878
2025
Q1 		$5.81M Buy
91,100
+52,400
+135% +$5.52M 0.01% 663
2024
Q4 		$4.71M Buy
38,700
+36,200
+1,448% +$4.44M 0.01% 788
2024
Q3 		$312K Sell
2,500
-27,700
-92% -$3.83M ﹤0.01% 1334
2024
Q2 		$4.77M Buy
+30,200
New +$3.88M 0.01% 671
2020
Q1 		– Sell
-20,000
Closed -$2.58M – 1201
2019
Q4 		$2.58M Buy
+20,000
New +$2.02M 0.01% 599
2018
Q1 		– Sell
-1,100
Closed -$61K – 1656
2017
Q4 		$61K Sell
1,100
-411,500
-100% -$21.8M ﹤0.01% 1488
2017
Q3 		$18.7M Buy
+412,600
New +$16.5M 0.04% 253
2017
Q1 		– Sell
-273,000
Closed -$7.58M – 1595
2016
Q4 		$7.58M Buy
+273,000
New +$11M 0.02% 440

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nomura Holdings's SRPT Position: Q2 2026 in Review

Nomura Holdings opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 95,000 shares worth $1.71M. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in SRPT as recently as Q3 2025.

Nomura Holdings first reported a position in SRPT in Q3 2014 and has held it in 23 quarters since. The position peaked at $24.9M in Q1 2019. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Nomura Holdings held 95,000 shares of Sarepta Therapeutics worth $1.71M as of Q2 2026.
  • Sarepta Therapeutics was a new Nomura Holdings position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1175 holding.
  • Nomura Holdings first reported a position in Sarepta Therapeutics in Q3 2014 and has held it in 23 quarters since.
  • Nomura Holdings's Sarepta Therapeutics position peaked at $24.9M in Q1 2019.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.